Farallon Capital: Q3 2026 13F
Multi-strategy firm founded by Tom Steyer.
Holdings as of Sep 30, 2026 (Q3 2026)Filed Nov 16, 202613F deadline Nov 16, 2026 (45 days after quarter end)
Portfolio at a glance
Largest stock and ETF positions sized by weight, coloured by change since the previous 13F.
Biggest moves
Estimated dollars bought and sold in Q3 2026 (change in shares × quarter-end price).
Top buys
Ranked by estimated dollars added: change in shares × quarter-end price.
| Stock | Change | Est. $ |
|---|---|---|
Warner Bros Discovery Inc | New | +$1.5B |
0KXI Roku Inc | New | +$633M |
Crh Plc | New | +$442M |
Kenvue Inc | New | +$442M |
Roivant Sciences Ltd | Added+52% | +$272M |
MSTR 0 12.01.29 Strategy Inc | Added+310.1% | +$253M |
BBIO Bridgebio Pharma Inc | Added+32.6% | +$231M |
Natera Inc | Added+17.2% | +$158M |
SMCI 3.5 03.01.29 Super Micro Computer Inc | New | +$152M |
BIIB Biogen Inc | Added+859% | +$138M |
Broadcom Inc | Added+21.2% | +$86M |
ASBH American Svgs Bk Na | New | +$82M |
EXEL Exelixis Inc | Added+9.1% | +$72M |
FRNM Freenome Inc | New | +$59M |
IOND Ionic Digital Inc | New | +$58M |
ARMK Aramark | Added+27% | +$53M |
MSTR 0 03.01.30 Strategy Inc | Added+1709.7% | +$43M |
Boston Scientific Corp | Added+7.3% | +$33M |
LBRX Lb Pharmaceuticals Inc | New | +$28M |
IMCR Immunocore Hldgs Plc | New | +$28M |
Top sales
Ranked by estimated dollars sold, including full exits.
| Stock | Change | Est. $ |
|---|---|---|
Electronic Arts Inc | Sold out | −$1.6B |
Thermo Fisher Scientific Inc | Trimmed-57.5% | −$407M |
Crinetics Pharmaceuticals In | Sold out | −$336M |
LNTH Lantheus Hldgs Inc | Trimmed-44.3% | −$246M |
Microsoft Corp | Trimmed-34.1% | −$195M |
TNGX Tango Therapeutics Inc | Trimmed-62.9% | −$193M |
Novo-Nordisk A S | Sold out | −$126M |
Unitedhealth Group Inc | Trimmed-17.5% | −$81M |
Amazon Com Inc | Trimmed-10% | −$66M |
VNET 2 10.01.27 Vnet Group Inc | Sold out | −$47M |
Aon Plc | Trimmed-10.3% | −$40M |
Merck & Co Inc | Sold out | −$26M |
WRBY Warby Parker Inc | Sold out | −$25M |
FRNM Perceptive Cap Solutions Cor | Sold out | −$24M |
Kkr & Co Inc | Trimmed-5.8% | −$22M |
Astrazeneca Plc | Trimmed-23.3% | −$22M |
ENTA Enanta Pharmaceuticals Inc | Trimmed-60.7% | −$19M |
AXTA Axalta Coating Sys Ltd | Sold out | −$16M |
Novartis Ag | Trimmed-29.8% | −$15M |
MSTR 2.25 06.15.32 Strategy Inc | Sold out | −$14M |
New positions
| Stock | Change | Est. $ |
|---|---|---|
Warner Bros Discovery Inc | New | +$1.5B |
0KXI Roku Inc | New | +$633M |
Crh Plc | New | +$442M |
Kenvue Inc | New | +$442M |
SMCI 3.5 03.01.29 Super Micro Computer Inc | New | +$152M |
ASBH American Svgs Bk Na | New | +$82M |
FRNM Freenome Inc | New | +$59M |
IOND Ionic Digital Inc | New | +$58M |
LBRX Lb Pharmaceuticals Inc | New | +$28M |
IMCR Immunocore Hldgs Plc | New | +$28M |
Asml Hldg Nv | New | +$24M |
Alibaba Group Hldg Ltd | New | +$20M |
ETRA Electra Therapeutics Inc | New | +$19M |
SUPN Indivior Pharmaceuticals Inc | New | +$16M |
LTGO Latigo Biotrapeutics Inc | New | +$14M |
Sold out
| Stock | Change | Est. $ |
|---|---|---|
Electronic Arts Inc | Sold out | −$1.6B |
Crinetics Pharmaceuticals In | Sold out | −$336M |
Novo-Nordisk A S | Sold out | −$126M |
VNET 2 10.01.27 Vnet Group Inc | Sold out | −$47M |
Merck & Co Inc | Sold out | −$26M |
WRBY Warby Parker Inc | Sold out | −$25M |
FRNM Perceptive Cap Solutions Cor | Sold out | −$24M |
AXTA Axalta Coating Sys Ltd | Sold out | −$16M |
MSTR 2.25 06.15.32 Strategy Inc | Sold out | −$14M |
BBNX Beta Bionics Inc | Sold out | −$9M |
SMG Scotts Miracle-Gro Co | Sold out | −$6M |
WAY Waystar Hldg Corp | Sold out | −$5M |
BC Brunswick Corp | Sold out | −$5M |
GNTX Gentex Corp | Sold out | −$5M |
Idexx Labs Inc | Sold out | −$5M |
Largest holdings
Top 30 of 114 stock and ETF positions, as of Sep 30, 2026. Options are listed separately below.
| Stock | Change | Value |
|---|---|---|
Revolution Medicines Inc | Unchanged | $2.8B |
Warner Bros Discovery Inc | New | $1.5B |
Natera Inc | Added+17.2% | $1.1B |
BBIO Bridgebio Pharma Inc | Added+32.6% | $937M |
PTGX Protagonist Therapeutics Inc | Unchanged | $907M |
EXEL Exelixis Inc | Added+9.1% | $858M |
Roivant Sciences Ltd | Added+52% | $795M |
0KXI Roku Inc | New | $633M |
Amazon Com Inc | Trimmed-10% | $590M |
GRAL Grail Inc | Trimmed-2.2% | $570M |
Boston Scientific Corp | Added+7.3% | $493M |
Broadcom Inc | Added+21.2% | $490M |
Crh Plc | New | $442M |
Kenvue Inc | New | $442M |
Twist Bioscience Corp | Unchanged | $413M |
Unitedhealth Group Inc | Trimmed-17.5% | $385M |
Microsoft Corp | Trimmed-34.1% | $376M |
Synopsys Inc | Added+3.4% | $373M |
Kkr & Co Inc | Trimmed-5.8% | $354M |
Aon Plc | Trimmed-10.3% | $343M |
MSTR 0 12.01.29 Strategy Inc | Added+310.1% | $328M |
LNTH Lantheus Hldgs Inc | Trimmed-44.3% | $310M |
Thermo Fisher Scientific Inc | Trimmed-57.5% | $301M |
LQDA Liquidia Corporation | Added+6.5% | $269M |
Wabtec | Unchanged | $252M |
BEAM Beam Therapeutics Inc | Unchanged | $251M |
ARMK Aramark | Added+27% | $247M |
IMVT Immunovant Inc | Added+11.5% | $219M |
AGIO Agios Pharmaceuticals Inc | Unchanged | $197M |
BIIB Biogen Inc | Added+859% | $154M |
Options (puts and calls)
13F reports options at the value of the underlying shares, not the premium paid, and can't show whether they hedge other positions. Kept out of buys, sales and rankings. Puts $4.0B, calls $0K.
Source: FARALLON CAPITAL MANAGEMENT, L.L.C., Form 13F-HR on SEC EDGAR, compared with the filing for Jun 30, 2026. 13F shows only US-listed long positions (plus listed options), is delayed up to 45 days, and estimated dollar changes assume the quarter-end price. Not investment advice. How we calculate this.